SUPRIYA Supriya Lifescience Limited
Healthcare
LTP
846.2
CHG · %
-22.2 (-2.56%)
VOL · TODAY
92.05K
PREV CLOSE
868.4
Today's range842.2 · 880.3
846.2
52-week range545.5 · 1,085
846.2
Loading candles…
Supriya Lifescience Ltd., headquartered in Mumbai, India, was initially established as a partnership in 1987 and later incorporated as a public limited company in 2008. The company operates in the pharmaceutical industry, specializing in the manufacturing and export of Active Pharmaceutical Ingredients (APIs). Its portfolio includes 38 APIs focused on therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic. Supriya Lifescience follows a backward-integrated business model supported by a specialized manufacturing facility and dedicated research and development capabilities. The company serves markets across India and exports to over 120 countries globally. It is recognized as a niche player within the global regulated life science sector.
SUPRIYA is not part of any active scan today.
This page is a live market overview for Supriya Lifescience Limited (SUPRIYA) on the BSE. As a listed security, Supriya Lifescience Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SUPRIYA before placing trades on tick2trade.
As of the latest feed, SUPRIYA last traded at ₹846.2 on BSE, down ₹22.2 (2.56%) from the previous close of ₹868.4. Today's session range is ₹842.2 – ₹880.3, against a 52-week band of ₹545.5 – ₹1,085. Traded volume today stands at 92.05K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SUPRIYA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SUPRIYA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Supriya Lifescience Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SUPRIYA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SUPRIYA option chain page linked from this overview.
// similar in healthcare326 total